- Jun 22, 2022
National Cancer Institute: Clinical Trials Information for Patients and Caregivers
- Jun 1, 2022
Dana-Farber's 2022 Multiple Myeloma Patient Symposium - Update on Multiple Myeloma Treatment
- May 15, 2022
You are central to the care team: Be Empowered - IMF Patient & Family Webinar - May 14, 2022
- May 7, 2022
PE: CDC Guidelines: How to prevent infections (Sepsis) while getting chemotherapy?
- Apr 19, 2022
Siteman Cancer Center: Autologous stem cell transplant at Siteman Cancer Center
- Apr 14, 2022
Teva Announces Launch of a First Generic Version of Revlimid® (lenalidomide capsules), in the U.S.
- Apr 13, 2022
How to Prevent Neutropenic Sepsis on Treatment? Know Your ANC (Absolute Neutrophil Count)
- Apr 11, 2022
MPE survey on myeloma and AL amyloidosis diagnosis
- Apr 1, 2022
IMF - International Myeloma Foundation: Patient Handbook 2022
- Mar 31, 2022
What is Multiple Myeloma? www.uptodate.com
- Mar 30, 2022
Explore MCT: Join us in creating the most comprehensive platform for Myeloma Clinical Trials
- Mar 29, 2022
The Binding Site: Freelite Overview
- Mar 2, 2022
What is a Myeloma Specialist Why do I Need one and How do I Find One? HealthTree University Myeloma
- Mar 1, 2022
Why is it important to become your own best advocate? HealthTree University Myeloma
- Dec 15, 2021
Multiple Myeloma Research Foundation - MMRF's The Right Track Program | High Impact Topic (HIT)
- Dec 12, 2021
Siteman Cancer Center: Learn about cancer clinical trials and the benefits they offer patients
- Dec 11, 2021
Multiple Myeloma Research Foundation - MMRF - Immunotherapy
- Dec 10, 2021
NCCN Animation for Patients: What is Multiple Myeloma?
- Dec 6, 2021
NCCN Patient Webinar: Multiple Myeloma